Many systems with peaks in the brain, testis, and skeletal muscle (RORα); GI tract, metabolic, and immune systems (RORγ); CNS (RORβ) In this SnapShot, we present information on a subgroup of the NRs called the orphan nuclear receptors. The cognate ligands for orphan receptors are either unknown or their physiological roles are not well characterized. The table here describes the major functions of these receptors, where they are expressed, their known target genes, and diseases associated with their abnormal activity. Symbols are given for the receptors as familiar symbol/Nuclear Receptor Nomenclature Committee name. Although human symbols are shown for the target genes of these receptors, regulation may have been demonstrated in human, mouse, or rat cells or tissues. In some cases, subfamily members that are encoded by distinct genes are discussed collectively. However, each receptor has specific contributions to the endocrine signaling axis in question. Certain NRs, such as DAX1 and SHP, decrease transcription of a particular target gene by repressing the activity of another NR or signaling pathway. In these cases, the direct target of the NR is given in brackets in the far-right column. For example, DAX1 inhibits SHF-1 activation of ARKR1B7.
Additional information, such as knockout phenotypes, transcriptomics, and cistromics, is available at the Nuclear Receptor Signaling Atlas (NURSA) website Molecule Pages (http://www.nursa.org) and in the references below. Specific literature on diseases associated with these receptors is at the Diseases and Phenotypes section of the NURSA Molecule Pages (http://www.nursa.org). For relative expression levels in specific tissues, see http://www.nursa.org/datasets.cfm?doi=10.1621/datasets.02001 and Bookout et al. (2006) . The ordering of receptors in the chart is based on visits to the NURSA Molecule Pages from May 2009-May 2010.
Abbreviations AML, acute myeloid leukemia; DBD, DNA-binding domain; CNS, central nervous system; DEHA, Bis(2-ethylhexyl) adipate; DEHP, Bis(2-ethylhexyl) phthalate; ERE, estrogen response element; GI, gastrointestinal; FAs, fatty acids; iPS, induced pluripotent stem cells; NA, not available; PCBs, polychlorinated biphenyls, PUFAs, polyunsaturated fatty acids; WAT, white adipose tissue.
